Edition:
United States

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

2.46USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
108,584
52-wk High
$5.14
52-wk Low
$1.86

Chart for

About

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $112.67
Shares Outstanding(Mil.): 45.43
Dividend: --
Yield (%): --

Financials

  AVXL.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.38 -- --
ROI: -71.50 1.96 12.83
ROE: -71.50 1.12 14.95

BRIEF-Anavex Life Sciences Reports Q2 Loss Per Share Of $0.11

* ANAVEX LIFE SCIENCES REPORTS FISCAL SECOND QUARTER 2018 FINANCIAL RESULTS

May 10 2018

Earnings vs. Estimates